Brigitte Ganter
Overview
Explore the profile of Brigitte Ganter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dasouki M, Rafi S, Olm-Shipman A, Wilson N, Abhyankar S, Ganter B, et al.
Blood
. 2013 Oct;
122(20):3440-9.
PMID: 24085763
We recently identified 2 siblings afflicted with idiopathic, autosomal recessive aplastic anemia. Whole-exome sequencing identified a novel homozygous missense mutation in thrombopoietin (THPO, c.112C>T) in both affected siblings. This mutation...
2.
Ganter B, Giroux C
Curr Opin Drug Discov Devel
. 2008 Jan;
11(1):86-94.
PMID: 18175271
Molecular pathway and network analysis tools that have been developed over the past decade provide an emerging systems-wide perspective for the analysis of gene expression, proteomic and metabolomic data. These...
3.
Ganter B, Zidek N, Hewitt P, Muller D, Vladimirova A
Pharmacogenomics
. 2007 Dec;
9(1):35-54.
PMID: 18154447
The pharmaceutical industry has begun to leverage a range of new technologies (proteomics, pharmacogenomics, metabolomics and molecular toxicology [e.g., toxicogenomics]) and analysis tools that are becoming increasingly integrated in the...
4.
Fu S, Ganter B, Lipsick J
Mol Cancer
. 2006 Nov;
5:54.
PMID: 17081304
Genes that cause cancer have been divided into two general classes--oncogenes that act in a dominant fashion to transform normal cells into a malignant state, and tumor suppressor genes that...
5.
Ganter B, Snyder R, Halbert D, Lee M
Pharmacogenomics
. 2006 Oct;
7(7):1025-44.
PMID: 17054413
A range of genomics technologies are increasingly becoming integrated with existing scientific disciplines to broaden and strengthen existing capabilities and open new avenues of research in drug discovery and development....
6.
Thompson K, Rosenzweig B, Pine P, Retief J, Turpaz Y, Afshari C, et al.
Nucleic Acids Res
. 2005 Dec;
33(22):e187.
PMID: 16377776
The comparability and reliability of data generated using microarray technology would be enhanced by use of a common set of standards that allow accuracy, reproducibility and dynamic range assessments on...
7.
Ganter B, Tugendreich S, Pearson C, Ayanoglu E, Baumhueter S, Bostian K, et al.
J Biotechnol
. 2005 Jul;
119(3):219-44.
PMID: 16005536
Successful drug discovery requires accurate decision making in order to advance the best candidates from initial lead identification to final approval. Chemogenomics, the use of genomic tools in pharmacology and...